OBJECTIVE: To determine whether the non-pneumatic anti-shock garment (NASG) can improve maternal outcome. METHODS: Women were enrolled in a pre-intervention phase (n=83) and an intervention phase (n=86) at a referral facility in Katsina, Nigeria, from November 2006 to November 2007. Entry criteria were obstetric hemorrhage (>or=750 mL) and a clinical sign of shock (systolic blood pressure <100 mm Hg or pulse >100 beats per minute). To determine differences in demographics, condition on study entry, treatment, and outcome, t tests and chi(2) tests were used. Relative risk (RR) and 95% confidence interval (CI) were estimated for the primary outcome, mortality. RESULTS: Mean measured blood loss in the intervention phase was 73.5+/-93.9 mL, compared with 340.4+/-248.2 mL pre-intervention (P<0.001). Maternal mortality was lower in the intervention phase than in the pre-intervention phase (7 [8.1%]) vs 21 [25.3%]) (RR 0.32; 95% CI, 0.14-0.72). CONCLUSION: The NASG showed potential for reducing blood loss and maternal mortality caused by obstetric hemorrhage-related shock.
OBJECTIVE: To determine whether the non-pneumatic anti-shock garment (NASG) can improve maternal outcome. METHODS:Women were enrolled in a pre-intervention phase (n=83) and an intervention phase (n=86) at a referral facility in Katsina, Nigeria, from November 2006 to November 2007. Entry criteria were obstetric hemorrhage (>or=750 mL) and a clinical sign of shock (systolic blood pressure <100 mm Hg or pulse >100 beats per minute). To determine differences in demographics, condition on study entry, treatment, and outcome, t tests and chi(2) tests were used. Relative risk (RR) and 95% confidence interval (CI) were estimated for the primary outcome, mortality. RESULTS: Mean measured blood loss in the intervention phase was 73.5+/-93.9 mL, compared with 340.4+/-248.2 mL pre-intervention (P<0.001). Maternal mortality was lower in the intervention phase than in the pre-intervention phase (7 [8.1%]) vs 21 [25.3%]) (RR 0.32; 95% CI, 0.14-0.72). CONCLUSION: The NASG showed potential for reducing blood loss and maternal mortality caused by obstetric hemorrhage-related shock.
Authors: Janet Turan; Oladosu Ojengbede; Mohamed Fathalla; Mohammed Mourad-Youssif; Imran O Morhason-Bello; David Nsima; Jessica Morris; Elizabeth Butrick; Hilarie Martin; Carol Camlin; Suellen Miller Journal: J Womens Health (Larchmt) Date: 2010-12-29 Impact factor: 2.681
Authors: Suellen Miller; Mohamed M F Fathalla; Oladosu A Ojengbede; Carol Camlin; Mohammed Mourad-Youssif; Imran O Morhason-Bello; Hadiza Galadanci; David Nsima; Elizabeth Butrick; Tarek Al Hussaini; Janet Turan; Carinne Meyer; Hilarie Martin; Aminu I Mohammed Journal: BMC Pregnancy Childbirth Date: 2010-10-18 Impact factor: 3.007
Authors: Mohammed Mourad-Youssif; Oladosu A Ojengbede; Carinne D Meyer; Mohammad Fathalla; Imran O Morhason-Bello; Hadiza Galadanci; Carol Camlin; David Nsima; Tarek Al Hussaini; Elizabeth Butrick; Suellen Miller Journal: Reprod Health Date: 2010-09-01 Impact factor: 3.223
Authors: Mohamed M F Fathalla; Mohammed Mourad Youssif; Carinne Meyer; Carol Camlin; Janet Turan; Jessica Morris; Elizabeth Butrick; Suellen Miller Journal: ISRN Obstet Gynecol Date: 2011-08-10
Authors: Musa Abubakar Kana; Henry Victor Doctor; Bárbara Peleteiro; Nuno Lunet; Henrique Barros Journal: BMC Public Health Date: 2015-04-09 Impact factor: 3.295
Authors: Alison El Ayadi; Sarah Raifman; Farouk Jega; Elizabeth Butrick; Yemisi Ojo; Stacie Geller; Suellen Miller Journal: PLoS One Date: 2013-08-08 Impact factor: 3.240
Authors: Tori Sutherland; Janelle Downing; Suellen Miller; David M Bishai; Elizabeth Butrick; Mohamed M F Fathalla; Mohammed Mourad-Youssif; Oladosu Ojengbede; David Nsima; James G Kahn Journal: PLoS One Date: 2013-04-30 Impact factor: 3.240
Authors: Suellen Miller; Eduardo F Bergel; Alison M El Ayadi; Luz Gibbons; Elizabeth A Butrick; Thulani Magwali; Gricelia Mkumba; Christine Kaseba; N T My Huong; Jillian D Geissler; Mario Merialdi Journal: PLoS One Date: 2013-10-23 Impact factor: 3.240